Preliminary Results of the FASM Study, an On-Going Italian Active Pharmacovigilance Project

• Main Authors: Giorgia Teresa Maniscalco (Author), Vincenzo Brescia Morra (Author), Ciro Florio (Author), Giacomo Lus (Author), Gioacchino Tedeschi (Author), Maddalena Cianfrani (Author), Renato Docimo (Author), Stefania Miniello (Author), Felice Romano (Author), Leonardo Sinisi (Author), Daniele L. A. Spitaleri (Author), Giuseppe Longo (Author), Ugo Trama (Author), Maria Triassi (Author), FASM Group (Author), Cristina Scavone (Author), Annalisa Capuano (Author)
• Format: Book
• Published: MDPI AG, 2020-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background and aim: Disease-modifying therapies (DMTs) used in multiple sclerosis (MS) have distinct safety profiles. In this paper, we report preliminary results of an on-going pharmacovigilance project (the FASM study). Results: Neurologists working at involved multiple sclerosis centers collected...